D. E. Shaw & Co., Inc. - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 275 filers reported holding IMMUNOGEN INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$111,014,443
-6.3%
6,995,239
+11.4%
0.12%
-4.1%
Q2 2023$118,513,337
+4822.7%
6,280,516
+1193.9%
0.12%
+3933.3%
Q4 2022$2,407,475
-25.8%
485,378
-28.5%
0.00%
-25.0%
Q3 2022$3,246,000
-26.2%
679,132
-30.5%
0.00%
-20.0%
Q2 2022$4,396,000
-26.2%
976,927
-22.0%
0.01%
-16.7%
Q1 2022$5,958,000
-56.8%
1,251,677
-32.6%
0.01%
-45.5%
Q4 2021$13,784,000
+16.5%
1,857,706
-11.0%
0.01%0.0%
Q3 2021$11,829,000
-17.4%
2,086,235
-4.0%
0.01%
-8.3%
Q2 2021$14,325,000
-3.4%
2,173,782
+18.7%
0.01%
-14.3%
Q1 2021$14,833,000
+83.1%
1,831,244
+45.8%
0.01%
+100.0%
Q4 2020$8,099,000
+37.1%
1,255,682
-23.5%
0.01%
+16.7%
Q3 2020$5,909,000
-49.9%
1,641,416
-35.9%
0.01%
-57.1%
Q2 2020$11,788,000
+47.6%
2,562,656
+9.4%
0.01%
+16.7%
Q1 2020$7,987,000
-38.7%
2,342,250
-8.3%
0.01%
-20.0%
Q4 2019$13,038,000
+317.5%
2,553,910
+97.9%
0.02%
+275.0%
Q3 2019$3,123,000
+191.1%
1,290,462
+161.0%
0.00%
+300.0%
Q2 2019$1,073,000
-18.2%
494,361
+2.2%
0.00%
-50.0%
Q1 2019$1,311,000
+1070.5%
483,839
+4106.2%
0.00%
Q2 2018$112,000
-90.7%
11,503
-89.9%
0.00%
-100.0%
Q1 2018$1,204,000
-46.4%
114,433
-61.0%
0.00%
-33.3%
Q3 2017$2,247,000
+19.7%
293,748
-39.4%
0.00%0.0%
Q1 2017$1,877,000
+104.7%
484,908
+7.9%
0.00%
+50.0%
Q4 2016$917,000
+639.5%
449,256
+867.9%
0.00%
Q3 2016$124,000
-84.1%
46,417
-49.2%
0.00%
-100.0%
Q1 2016$778,000
-90.8%
91,297
-85.4%
0.00%
-92.3%
Q4 2015$8,497,000
+75.8%
626,129
+24.4%
0.01%
+85.7%
Q3 2015$4,833,000
+1242.5%
503,405
+1913.1%
0.01%
+600.0%
Q2 2015$360,000
-83.0%
25,006
-89.5%
0.00%
-66.7%
Q1 2015$2,122,000
-44.4%
237,175
-62.1%
0.00%
-40.0%
Q4 2014$3,814,000
+2079.4%
625,169
+5243.3%
0.01%
Q1 2014$175,000
+1.7%
11,7000.0%0.00%
Q4 2013$172,00011,7000.00%
Other shareholders
IMMUNOGEN INC shareholders Q3 2023
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 600,000$3,870,0002.25%
CM Management, LLC 375,000$2,419,0002.24%
Consonance Capital Management LP 3,515,944$22,678,0002.12%
RA Capital Management 18,417,458$118,793,0001.66%
Kercheville Advisors, LLC 244,421$1,564,0000.85%
Redmile Group, LLC 10,528,179$67,907,0000.82%
Birchview Capital, LP 190,000$1,226,0000.71%
QVT Financial LP 1,375,900$8,875,0000.49%
Fernwood Investment Management, LLC 149,340$963,0000.38%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$671,0000.21%
View complete list of IMMUNOGEN INC shareholders